Shire/Noven's Daytrana Receives FDA Wake-up Call: Side Effects Greater Than Concerta, Agency Says

FDA will ask FDA's Psychopharmacologic Drugs Advisory Committee whether the methylphenidate patch is "acceptably safe" for approval at Dec. 2 meeting.